Skip to main content

Table 2 Clinical features and laboratory findings of the patients in acute stage (n = 143)

From: Post-chikungunya arthritis: a longitudinal study in a tertiary care hospital in Bangladesh

Clinical features

n (%)

Fever

143 (100)

Symmetrical joint involvement

121 (84.6)

Joint involvement at onset

 

 Generalized

96 (67.1)

 Ankle

22 (15.4)

 Knee

15 (10.5)

 Others

10 (6.9)

Subsequent joint involvement

 

 Ankle

119 (83.2)

 Metacarpophalangeal joint

100 (69.9)

 Wrist

97 (67.8)

 Proximal interphalangeal joints

84 (58.7)

 Knee

76 (53.1)

 Shoulder

64 (44.8)

 Elbow

51 (35.7)

 Metatarsophalangeal joint

46 (32.2)

 Distal interphalangeal joints

43 (30.1)

 Others (hip, temporomandibular joint, axial plane)

30 (20.9)

Joint swelling

68 (47.6)

Morning stiffness

117 (81.8)

Myalgia

47 (32.9)

Skin involvement

91 (63.6)

Pattern of skin involvement

 

 Pruritic erythematous rash

67 (46.9)

 Erythematous rash

24 (16.8)

Functional disability

 

 Mild

79 (55.2)

 Moderate

49 (34.3)

 Severe

15 (10.5)

Laboratory findings

 

Positive Immunoglobulin M (IgM)

135 (94.4)

Positive Immunoglobulin G (IgG)

29 (20.3)

C-reactive protein (CRP) positive (n = 48)

39 (81.2)

Erythrocyte sedimentation rate (mm in 1st hour), median [IQR]

31.0 [15.0–45.0]

White blood cells count (103/µL), mean ± SD

8.4 ± 2.4

Platelet count (103/µL) mean ± SD

297.1 ± 91.7

Serum creatinine (mg/dl)

0.8 ± 0.2

  1. *IQR Inter-quartile range